Home
Edward Morrow Atkinson III, EVP, Chief Technical Ops. Off: Vertex Pharmaceuticals VRTX Sell · Filed 02/19
Trade details
- Type
- Insider sale
- Amount
- $994,093.26
- Shares · price
- 2,031 sh · $489.46 a share
- Held after
- 21,544 sh
- Trade date
- 26/02/17
- Filed
- 26/02/19
- Days to filing
- 2 days
Sold 8.6% of holdings
- Share of holding sold
- 8.6%
Vertex Pharmaceuticals trades, last 26 weeks
What else happened in Vertex Pharmaceuticals around then
Filed or reported within 30 days of the trade day · 01/18~03/19Edward Morrow Atkinson III's recent trades
- Edward Morrow Atkinson III
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 planVertex Pharmaceuticals
VRTX
$324.9K
668 sh
$324.9K
Filed 02/26
Traded 02/25
- Edward Morrow Atkinson III
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 planVertex Pharmaceuticals
VRTX
$324.9K
668 sh
$324.9K
Filed 02/25
Traded 02/25
- Edward Morrow Atkinson III
Sell10b5-1 planVertex Pharmaceuticals
Sell10b5-1 planVertex Pharmaceuticals
VRTX
$387K
817 sh
$387K
Filed 02/19
Traded 02/18
- Edward Morrow Atkinson III
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 planVertex Pharmaceuticals
VRTX
$387K
817 sh
$387K
Filed 02/18
Traded 02/18
- Edward Morrow Atkinson III
Planned sale10b5-1 planVertex Pharmaceuticals
Planned sale10b5-1 planVertex Pharmaceuticals
VRTX
$994.1K
2,031 sh
$994.1K
Filed 02/17
Traded 02/17